Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Work In Process (2011 - 2025)

Updated

Sinovac Biotech (SVA) reported Work In Process of $38.88 million for Q4 2025, up 4.9% from $37.05 million a year earlier.

Analysis

Sinovac Biotech (SVA) Work In Process (2011 - 2025) Analysis & Trends

Dating back to Q4 2011, Sinovac Biotech's Work In Process record includes 13 quarters.

  • Work In Process has a five-year compound annual growth rate of -5.8% (FY2020 to FY2025).
  • By year, Work In Process came in at $37.05 million in FY2024 (-5.9%), $39.37 million in FY2023 (-4.3%), $41.12 million in FY2022 (-70.9%) and $141.33 million in FY2021 (+169.1%).
  • The Q4 2025 figure ranks as the highest quarterly Work In Process since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,170.99 Bn 1,139.58 Bn 19.71 Bn
2 Johnson & Johnson 642.25 Bn 560.77 Bn 17.26 Bn
3 AbbVie 502.08 Bn 475.19 Bn 12.70 Bn
4 Merck 375.61 Bn 329.99 Bn 12.21 Bn
5 Novartis Ag 302.76 Bn 266.75 Bn 11.24 Bn
6 Astrazeneca 268.66 Bn 242.35 Bn 12.86 Bn
7 Amgen 241.98 Bn 197.38 Bn 7.24 Bn
8 Gilead Sciences 193.37 Bn 167.57 Bn 6.22 Bn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn
10 Sinovac Biotech 464.94 Mn -35.05 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 38.88 Mn
Dec 31, 2024 37.05 Mn
Dec 31, 2023 39.37 Mn
Dec 31, 2022 41.12 Mn
Dec 31, 2021 141.33 Mn
Dec 31, 2020 52.52 Mn
Dec 31, 2019 8.57 Mn
Dec 31, 2018 3.93 Mn
Dec 31, 2017 3.28 Mn
Dec 31, 2014 4.06 Mn
Dec 31, 2013 448,000.00
Dec 31, 2012 971,000.00
Dec 31, 2011 446,468.00
API Access

Sinovac Biotech Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=SVA&period=max&api_key=YOUR_API_KEY